Results
20,958 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer |  ALNYALNYLAM PHARMACEUTICALS, INC.Open-market sale | SELL | $13K 34 sh | Jan 14, 2026 traded Jan 12, 2026 | |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $13K 34 sh | Jan 14, 2026 traded Jan 12, 2026 | |
Garg PushkalEVP Chief R&D |
| ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale |
| SELL |
| $18K 50 sh |
| Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $15K 40 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Neale Erin RoseSVP, Chief Legal Officer |  SNCYSun Country Airlines Holdings, Inc.Open-market sale | SELL | $40K 2,257 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $35K 98 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 |  Wood Anthony J.Director, CEO and Chairman BOD, 10% Owner |  ROKUROKU, INCOpen-market sale · 10b5-1 plan | SELL | $1.62M 14.6K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Wood Anthony J.Director, CEO and Chairman BOD, 10% Owner | ROKUROKU, INC Open-market sale · 10b5-1 plan | SELL | $2.49M 22.6K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $34K 92 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $15K 41 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $15K 42 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Bevirt JoeBenDirector, CEO and Chief Architect, 10% Owner |  JOBYJoby Aviation, Inc.Open-market sale | SELL | $24K 1,630 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 36 | McBee BranninChief Development Officer |  CRWVCoreWeave, Inc.Open-market sale · 10b5-1 plan | SELL | $387K 4,240 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $5,242 14 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $34K 96 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $15K 41 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $26K 73 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $49K 135 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $26K 73 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $44K 123 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $5,667 15 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $5,667 15 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $10K 27 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $13K 36 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $34K 96 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 35 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $459K 1,259 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 35 | Frank MalcolmDirector |  FDSFACTSET RESEARCH SYSTEMS INCOpen-market sale | SELL | $308K 1,045 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 35 | Armenta AnthonyChief Software & Data Officer |  SERVServe Robotics Inc. /DE/Open-market sale | SELL | $56K 3,893 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 35 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $279K 778 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 35 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $353K 980 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 35 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $510K 1,395 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 33 | Soule Randy10% Owner |  SAFXXCF Global, Inc.Open-market sale | SELL | $31K 200.0K sh | Jan 14, 2026 traded Jan 9, 2026 |
| 33 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $156K 1,727 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 33 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $62K 693 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 33 | Soule Randy10% Owner | SAFXXCF Global, Inc. Open-market sale | SELL | $32K 200.0K sh | Jan 14, 2026 traded Jan 9, 2026 |
| 33 | Soule Randy10% Owner | SAFXXCF Global, Inc. Open-market sale | SELL | $32K 200.0K sh | Jan 14, 2026 traded Jan 9, 2026 |
| 33 | Lo FrancisChief People Officer |  ADPTAdaptive Biotechnologies CorpOpen-market sale · 10b5-1 plan | SELL | $1.41M 79.6K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 33 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $129K 1,414 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $646K 7,254 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Wood Anthony J.Director, CEO and Chairman BOD, 10% Owner | ROKUROKU, INC Open-market sale · 10b5-1 plan | SELL | $1.58M 14.5K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $96K 269 sh | Jan 14, 2026 traded Jan 12, 2026 |